Alcon Research, Ltd (M.M.G.), Johns Creek, GA; Alcon Research, Ltd (C.M., R.W., L.C., M.C., S.S.), Fort Worth, TX; and Novartis Pharmaceuticals Corporation (J.B.), Global Drug Development, Fort Worth, TX.
Address correspondence to Manal M. Gabriel, PhD, Alcon Research Ltd, 11460 Johns Creek Parkway, Johns Creek, GA 30097; e-mail: [email protected]
The authors have no funding or conflicts of interest to disclose.
M. M. Gabriel is an employee of Alcon Research, Ltd, Johns Creek, GA, USA. C. McAnally, R. Walters, L. Clark, M. Crary, and S. Shannon are employees of Alcon Research, Ltd, Fort Worth, TX. J. Bartell is an employee of Novartis Pharmaceuticals Corporation, Global Drug Development, Fort Worth, TX.
Parts of the study results have been presented previously at the American Academy of Optometry 93rd Annual Meeting, Denver, CO, November 12 to 15, 2014; the Association of Research in Vision and Ophthalmology Annual Meeting, Denver, CO, May 3 to 7, 2015; and the British Contact Lens Association 39th Clinical Conference, Liverpool, UK, May 29 to 31, 2015.